Big names, big com­pa­nies back a cell ther­a­py start­up run by a high-pro­file re­gen­er­a­tive med ex­pert

One of the best known names in re­gen­er­a­tive med­i­cine is launch­ing a new biotech with as­sets and cash com­ing from a range of mar­quee com­pa­nies …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.